Abstract

Soft tissue tumors represent a heterogeneous group of neoplasms originating from non-epithelial structures, presenting diagnostic and therapeutic challenges. This abstract highlights the complexity of soft tissue tumors and discusses recent advancements in patient care. Molecular profiling techniques have revolutionized our understanding of these tumors, identifying molecular alterations and signaling pathways that guide personalized treatment approaches. Multimodal treatment strategies, including surgery, radiation therapy, and systemic therapies, are employed to optimize patient outcomes. Emerging therapeutic strategies, such as immunotherapy and targeted therapies, show promise in improving outcomes for patients with soft tissue tumors. Collaboration among various disciplines and the establishment of registries and networks facilitate comprehensive patient evaluation and foster research. By unveiling the complexity of soft tissue tumors and advancing patient care, we strive to improve treatment outcomes and provide personalized interventions in this challenging field.